Product Strategy

A cancer diagnostics company wanted to understand the current and future landscape for RNA-based oncology biomarkers, focusing on gene expression profiling (GEP) and rearrangements across medical settings

A multi-billion dollar life science company needed pre-diligence on a potential acquisition target

A leading diagnostics player asked DeciBio to characterize the evolving NIPT market to help inform strategic positioning regarding menu offerings and technological approach

A large pharma new to precision oncology wanted to understand the processes and requirements to ensure that their novel CDx was included into diagnostic guidelines globally

A leading diagnostics player wanted an assessment of the current and future carrier screening landscape to guide their product development strategy

A diagnostics player wanted to determine which indications / use cases to target and develop a product road map